|
Model Number MMT-332A |
Device Problems
Break (1069); Fluid/Blood Leak (1250); Improper Flow or Infusion (2954)
|
Patient Problem
Hyperglycemia (1905)
|
Event Date 02/02/2024 |
Event Type
Injury
|
Manufacturer Narrative
|
This mdr related to the puerto rico manufacturing site has been assigned a medwatch number from the medtronic minimed northridge site, per variance 5.Currently it is unknown whether or not the device may have caused or contributed to the event as no product has been returned.The device will be returned for analysis and further information will follow once the analysis has been completed.No conclusion can be drawn at this time.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
Information received by medtronic indicated that the customer experienced hyperglycemia with a blood glucose value at the time of incident :unknown mg/dl and current blood glucose value: 401 mg/dl.The customer also reported reservoir leak, which lead to the high blood glucose event.Troubleshooting was performed and found that the customer was treated with insulin pump.The leak passed the 2nd o-ring.The air bubbles present in the reservoir.Its unknown whether the insulin pump was used within 48 hours and its unknown whether the auto mode feature was active at the time of the event.No further patient complications were reported.The customer will continue using the insulin pump.The insulin pump will not be returned for analysis.
|
|
Manufacturer Narrative
|
Evaluated 2 open/used reservoirs (no liquid inside the barrels) transfer guards not returned.A visual inspection was performed using appendix d; checked o-rings and stopper groove for defects and none was found, using a new lab transfer guard; reservoirs were reconnected.Performed pre-fill test appendix c.Found no air bubbles and no leaks during analysis.Per (b)(4).Conclusion: reservoirs passed per pre-fill test; no air bubbles, no leaks and no physical anomalies were found during test.Cosmetic anomalies were found, disassembled components.See attached file for more details.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employees caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|